03:44 PM EDT, 07/14/2026 (MT Newswires) -- Robert I Blum, Director, President & CEO, on July 13, 2026, sold 7,500 shares in Cytokinetics ( CYTK ) for $615,150. Following the Form 4 filing with the SEC, Blum has control over a total of 381,986 common shares of the company, with 377,820 shares held directly and 4,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000106198326000077/xslF345X05/form4.xml

Price: 81.68, Change: -0.56, Percent Change: -0.68